1. DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage
   Thom G. A. Reuvers et al, 2020, Cancers CrossRef
2. The high toxicity of DSB-clusters modelling high-LET-DNA damage derives from inhibition of c-NHEJ and promotion of alt-EJ and SSA despite increases in HR
   Veronika Mladenova et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
3. Theranostic Terbium Radioisotopes: Challenges in Production for Clinical Application
   Nabanita Naskar et al, 2021, Frontiers in Medicine CrossRef
4. Therapeutic Efficacy of Variable Biological Effectiveness of Proton Therapy in U-CH2 and MUG-Chor1 Human Chordoma Cell Death
   Prerna Singh et al, 2021, Cancers CrossRef
5. Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
   Katherine A. Morgan et al, 2023, Chemical Reviews CrossRef
6. Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
   Ashutosh Dash et al, 2020, Current Medicinal Chemistry CrossRef
7. A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)
   Kaat Spoormans et al, 2022, Pharmaceutics CrossRef
8. Alpha Radiation as a Way to Target Heterochromatic and Gamma Radiation-Exposed Breast Cancer Cells
   Maja Svetličič et al, 2020, Cells CrossRef